News
Sanofi swoops on Dynavax with $2.5bn takeover deal
Sanofi's last job before breaking up for the Christmas holiday? Putting the finishing touches on a $2.5bn agreement to buy vaccine firm Dynavax.
R&D
How labs can lead the way in sustainability
Through focused strategies and industry collaboration, labs can significantly reduce waste, energy usage, and emissions.
R&D
Searching for new weight loss treatments
Using IP intelligence to guide R&D activity can also help companies to develop treatments that are more effective, with fewer side effects.
R&D
On genomics, NGS, and doing much more good than bad, with Ma...
Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.
News
Ipsen licenses Simcere ADC in $1bn-plus deal
Deal-hungry Ipsen is at it again, pledging around $1bn for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
